Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-to-participate-in-noble-capital-markets-emerging-growth-virtual-healthcare-equity-conference-on-april-18-2024-302114776.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-provides-fourth-quarter-2023-corporate-update-302084864.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-to-participate-at-technology-and-heart-failure-therapeutics-tht-conference-302070595.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-appoints-jeff-cole-as-chief-operating-officer-in-advance-of-tecarfarin-phase-3-pivotal-trial-302057004.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-to-present-at-the-biotech-showcase-on-january-8-2024-alongside-the-jp-morgan-annual-healthcare-conference-302025890.html
https://www.prnewswire.com/news-releases/noble-capital-markets-initiates-coverage-on-cadrenal-therapeutics-with-outperform-rating-and-us4-00-price-target-302018426.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-engages-the-sage-group-to-advance-tecarfarins-late-stage-development-and-commercialization-302012016.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-provides-third-quarter-2023-corporate-update-301982673.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-highlights-additional-need-for-a-new-vitamin-k-antagonist-tecarfarin-following-updates-from-the-recent-european-society-of-cardiology-congress-301917398.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-expands-evaluation-of-tecarfarin-for-patients-with-antiphospholipid-syndrome-aps-301913344.html